BBOT BRIDGEBIO ONCOLOGY THERAPEUT
FollowCL A ORD SHS (common), issuer CIK 1869105
0 managers (0 13F filers) reported a position in BBOT shares at 2025-09-30. 0 filers opened a position and 33 filers sold out during the quarter.
- Managers
- 0
- 13F filers
- 0
- New
- 0
- Added
- 0
- Reduced
- 0
- Sold out
- 33
- Shares held by filers
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Beltran Pedrodirector, officer (President and CEO) | 2026-11-18 | -1,870 S | $1.841 | Form 4 |
| Cobo Marcofficer (Principal Accounting Officer) | 2026-11-13 | -78 S | $2.37 | Form 4 |
13F holders, Q3 2025
Filers in the available 13F reports with a share position at 2025-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|
Events
Beltran Pedro sold 1,870 BBOT shares on 2026-11-18, Form 4 filed 2026-11-20. 0001193125-26-470272
Accepted , ingestedCobo Marc sold 78 BBOT shares on 2026-11-13, Form 4 filed 2026-11-17. 0001193125-26-465625
Accepted , ingested